ACS DOBFAR S.p.A. (manufacturing, primary and secondary packaging, quality control, batch release; manufacturing and quality control of sterile mixture)
UkraineAll drugs from this manufacturer
-
The drug is prescribed for the treatment of pneumonia, bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, infections during and after childbirth, as well as acute bacterial meningitis. It can also be used in bacteremia and in patients with neutropenia.
Dosage form: powder for injection solution
Active substance Dosage meropenem 1000 mg ATC: J01DH02
-
The drug is prescribed for the treatment of pneumonia (hospital-acquired and community-acquired), bronchopulmonary infections in cystic fibrosis, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, infections during and after childbirth, as well as acute bacterial meningitis.
Dosage form: powder for injection solution
Active substance Dosage meropenem 500 mg ATC: J01DH02
-
The drug is prescribed for the treatment of various infections in adults and children (from 3 months of age), including pneumonia, bronchopulmonary infections in cystic fibrosis, complicated urinary tract, intestinal, skin, and soft tissue infections, infections during and after childbirth, as well as acute bacterial meningitis.
Dosage form: powder for injection solution
Active substance Dosage meropenem 2000 mg ATC: J01DH02